Allston, MA · Founded 2020 · Privately Held (backing)
Developer of oncological drugs designed to treat RAS-driven cancers and bring a new therapy to cancer's frequently mutated oncogenic target. Kestrel Therapeutics is based in Allston, MA and was founded in 2020. Its last reported valuation was $17.7 million in Jan 2022. It has raised $20.7 million across 3 recorded rounds; the latest was a $5 million early-stage round in Jul 2025.
Last reported valuation
$17.7M
Oct 2026
Priced at
—
Total raised
$20.7M
Last round
Early Stage VC
Jul 2025
Team — not yet on record
No current team members for Kestrel Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kestrel Therapeutics with a free account
·Watch Kestrel Therapeutics: the Monday email on marks, rounds and moves
